https://cdnmundo1.img.sputniknews.com/i/logo-itemprop.png
Sputnik Mundo
https://cdnmundo2.img.sputniknews.com/i/logo.png
—
Sputnik
https://cdnmundo2.img.sputniknews.com/i/logo.png
—
https://mundo.sputniknews.com/oriente-medio/202007141092081127-cientificos-israelies-descubren-efectos-de-medicina-para-el-colesterol-sobre-el-covid-19/
–
TEL AVIV (Sputnik) – The drug Fenofibrate (brand name TriCor), used to lower cholesterol, may be useful in the treatment of COVID-19, the press service from the Hebrew University of Jerusalem reported.
–
“Can a simple medicine present on the market for dozens of years be used in the COVID-19 treatment? The team of researchers at the Hebrew University of Jerusalem says the first studies look promising, “according to the statement.
Israeli scientists have spent three months studying the impact of the SARS-CoV-2 coronavirus on the lungs of infected people.
The coronavirus prevents the breakdown of carbohydrates and as a result fats accumulate in the cells, perfect condition for the virus to reproduce.
According to laboratory studies, the drug Fenofibrate “allows cells to burn more fat” and also “prevents reproduction of SARS-CoV-2“.
Only in five days of treatment did the patients defeat the virus almost completely.
“If clinical trials confirm our conclusions, such therapy may potentially reduce the severity of COVID-19 to the level of a cold,” said biologist Yaakov Nahmias.
–
